Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
G.LindquistS
This decrease in NLR suggests a reduction in systemic inflammation, which could lead to better skin health outcomes
Week 1-2: 0.5mg to 1mg once daily Week 3-4: 1mg once daily Week 5 onward: 1mg to 1.5mg once daily This gradual approach lets researchers assess tolerance
Advantages: Localized delivery to target tissue (skin, scalp) Non-invasive Lower systemic exposure Well-tolerated with established safety record in cosmeceuticals Limitations: Limited dermal penetration (molecular weight ~340 Da near the cutoff for transdermal absorption) No systemic anti-aging or anti-inflammatory effects Efficacy dependent on formulation vehicle (liposomal carriers significantly improve penetration) GHK-Cu Injection (Subcutaneous) GHK-Cu injection is explored in research settings for systemic administration
US$ 21.15
US$ 26.07
US$ 25.42
